Are you 60 or older? Have difficulty leaving home without help? If you are not receiving home-delivered meals, you may be eligible to participate in a University of Maryland Study on nutrition.

Research Participants Wanted – Can You Help or Do You Know Someone Who’d be Eligible to Participate?

From the Department of Nutrition and Food Sciences, UMD

Project 1- Phone Interview 

The University of Maryland is conducting interviews and is looking for participants!  We are interviewing adults age 60+ who have difficulty leaving home without help, and who are NOT receiving home-delivered meals.  Those who participate will receive $10 for completing a 30-45 minute interview.  Interviews are on-going through Spring 2020 and take place over the phone.  The questions are about the foods that you eat, and how your health may impact your daily activities and the quality of your life.  If you are age 60+, have difficulty leaving home without help, and are not receiving home-delivered meals, please call Anna Vaudin at 301-500-9154, or email her at  (Home-delivered meal applicants are still eligible for interviews if they have not started meal service yet!)  If you know someone who is eligible for an interview, please provide them with this information so they can get in touch!

Project 2  In-Person Interview

The University of Maryland is conducting interviews and is looking for participants!  Those who participate will receive $10 for completing a 45-60 minute interview.  The interview is about difficulties older adults may have with getting food and preparing food, the resources they choose to use to deal with these difficulties, and what impacts quality of life as we age.  Interviews will begin in February and can take place in your home or in a private community space of your choosing.  If you are age 60+ and are interested, please call Anna Vaudin at 301-500-9154 to set up an appointment, or email her at

The science of psilocybin and its use to prevent sufffering

“Johns Hopkins is deeply committed to exploring innovative treatments for our patients. Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential.”
– Paul B. Rothman, M.D., Dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine. 

Scientists today are entering a new era of studying a truly unique class of pharmacological compounds known as psychedelics. Although research with these compounds was first started in the 1950s and ‘60s, it abruptly ended in the early 1970s in response to unfavorable media coverage, resulting in misperceptions of risk and highly restrictive regulations.

After a decades-long hiatus, in 2000 our research group at Johns Hopkins was the first to obtain regulatory approval in the United States to reinitiate research with psychedelics in healthy volunteers. Our 2006 publication on the safety and enduring positive effects of a single dose of psilocybin is widely considered the landmark study that sparked a renewal of psychedelic research world-wide.

Since that time, we have published further groundbreaking studies in more than 60 peer-reviewed articles in respected scientific journals. This makes Johns Hopkins the leading psychedelic research institution in the U.S., and among the few leading groups worldwide. Our research has demonstrated therapeutic effects in people who suffer a range of challenging conditions including addiction (smoking, alcohol, other drugs of abuse), existential distress caused by life-threatening disease, and treatment-resistant depression. Studying healthy volunteers has also advanced our understanding of the enduring positive effects of psilocybin and provided unique insight into neurophysiological mechanisms of action, with implications for understanding consciousness and optimizing therapeutic and non-therapeutic enduring positive effects.

At the Center for Psychedelic and Consciousness Research, researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.

To watch a TED talk on this topic, click on the following link:

Happiness improves with age

In the 20th century we added an unprecedented number of years to our lifespans, but is the quality of life as good? Surprisingly, yes! Psychologist Laura Carstensen shows research that demonstrates that as people get older they become happier, more content, and have a more positive outlook on the world.

To view a video of her TED talk, click on the following link: